Who is sponsoring NCT05193877?

NCT05193877 is sponsored by Global Stem Cell Center, Baghdad.

What condition does NCT05193877 study?

NCT05193877 studies Treatment Complication.

Is NCT05193877 still recruiting?

NCT05193877 is currently completed. Last updated 17 January 2024.

Last reviewed 2024-01-17 · How we verify

NCT05193877

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Autologous Bone Marrow Aspirate Concentrate Injection for the Treatment of Early Osteoarthritis:Baghdad 2022

Completed NA Last updated 17 January 2024

What this trial tests

NA trial testing autologous bone marrow aspirate concentrate by centrifugation in Treatment Complication in 60 participants. Completed in 16 January 2024.

Timeline

8 February 2022

Primary endpoint
16 January 2024

16 January 2024

Quick facts

Lead sponsor	Global Stem Cell Center, Baghdad
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	8 February 2022
Primary completion	16 January 2024
Estimated completion	16 January 2024
Sites	1 location across Iraq

Drugs / interventions tested

autologous bone marrow aspirate concentrate by centrifugation

Conditions studied

Treatment Complication — all drugs for Treatment Complication →

Sponsor

Global Stem Cell Center, Baghdad

Who can join

Adults 55 to 85, any sex, with Treatment Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We present a randomized controlled trial (RCT) to assess the efﬁcacy of autologous bone marrow aspirate concentrate BMAC of 1.8x 10 9 median cellular content in the treatment of early symptomatic knee OA. We use 2 injections 2 months apart (8).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Stem cell injections for osteoarthritis of the knee.
Whittle SL, Johnston RV, McDonald S, Worthley D, et al · · 2025 · cited 11× · PMID 40169165 · DOI 10.1002/14651858.cd013342.pub2

Verify or expand the search:

Other recruiting trials for Treatment Complication

Currently open trials in the same condition.

NCT06373471 — Improving Quality of Life in Older Patients With Frailty and Hematological Cancer Through Geriatric Assessment · NA · recruiting
NCT06152198 — Functional Outcome After ORIF or Arthroplasty for Femoral Neck Fracture · NA · recruiting

Other Global Stem Cell Center, Baghdad trials

Trials by the same sponsor.

NCT07374185 — Using Autologous Bone Marrow Cells With Wharton Gel Exosomes to Stimulate Hepatic Cell Repair in Liver Cirrhosis · NA · not yet recruiting
NCT05982054 — Bone Marrow Cells With Core Decompression for AVN Treatment · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05193877 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Global Stem Cell Center, Baghdad
Last refreshed: 17 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05193877.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing